(Q81079656)
Statements
Superiority of protease inhibitors over nonnucleoside reverse-transcriptase inhibitors when highly active antiretroviral therapy is resumed after treatment interruption (English)
Pablo Barreiro
Carmen de Mendoza
Juan González-Lahoz